No 1 Date of announcement 2025/12/19 Time of announcement 17:51:27 Addresser Shu-Ling Cheng Addresser’s Position President Addresser’s Phone Number 02-26558860 Subject Bonvadis topical cream received medical device import license for all indications in wounds for India To which item it meets Subparagraph 10 Date of events 2025/12/19 Statement Date of occurrence of the event:2025/12/19...Read More
No 1 Date of announcement 2025/12/17 Time of announcement 16:39:53 Subject Oneness announces information about the third investor conference in 2025. To which item it meets paragraph 12 Date of events 2025/12/24 Statement Date of institutional investor conference: 2025/12/24 Time of institutional investor conference: 15:00 (GMT+8) Location of institutional investor conference: Online Investor Conference...Read More
No 1 Date of announcement 2025/11/12 Time of announcement 16:54:15 Subject Oneness Biotech Co., Ltd. receives a Canadian patent titled “TOPICAL FORMULATION FOR PROMOTING WOUND HEALING” on Fespixon cream (Research code: ON101). To which item it meets Subparagraph 53 Date of events 2025/11/12 Statement Date of occurrence of the event：2025/11/12 Company name: ONENESS BIOTECH...Read More
No 1 Date of announcement 2025/11/11 Time of announcement 23:07:40 Subject The medical device registration application of Bonvadis for all indications of wounds has been accepted by Health Canada. To which item it meets Subparagraph 10 Date of events 2025/11/11 Statement Date of occurrence of the event：2025/11/11 New drug name or code： Bonvadis Indication：Wound...Read More
No 1 Date of announcement 2025/11/10 Time of announcement 16:44:25 Subject The Company’s 2025Q3 consolidated financial statements have been approved by the Board of Directors. To which item it meets Subparagraph 10 Date of events 2025/11/10 Statement Date of the board of directors submitted or approved:2025/11/10 Date of the audit committee approved:2025/11/10 Start and...Read More
Published Date:2025-10-27 Original Link:https://www.onenessbio.com/en/news_detail385_1.htm No 1 Date of announcement 2025/10/27 Time of announcement 16:22:18 Subject The medical device registration application of Bonvadis for all indications of wounds has been accepted by Argentina National Administration of Drugs, Foods, and Medical Devices (ANMAT). To which item it meets Subparagraph 10 Date of events 2025/10/27 Statement Date...Read More
Published Date:2025-10-03 Original Link:https://www.onenessbio.com/en/news_detail385_1.htm No 1 Date of announcement 2025/10/03 Time of announcement 17:06:49 Subject The medical device registration application of Bonvadis for all indications in wounds has been accepted by ThaiFDA. To which item it meets Subparagraph 10 Date of events 2025/10/03 Statement Date of occurrence of the event：2025/10/03 New drug name or...Read More
No 2 Date of announcement 2025/10/03 Time of announcement 17:20:21 Subject The medical device registration application of Bonvadis for all indications of wounds has been accepted by COFEPRIS in Mexico. To which item it meets Subparagraph 10 Date of events 2025/10/03 Statement 1. Date of occurrence of the event:2025/10/03 2. New drug...Read More
Published Date:2025-09-17 Original Link:https://www.onenessbio.com/en/news_detail387_1.htm No 1 Date of announcement 2025/09/17 Time of announcement 15:55:15 Subject A Thailand patent on the Anti-CεmX (FB825) antibody was granted To which item it meets Subparagraph 53 Date of events 2025/09/17 Statement 1.Date of occurrence of the event:2025/09/17 2.Company name:ONENESS BIOTECH CO., LTD 3.Relationship to the Company (please...Read More
